Jump Financial’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Jump Financial's DGX Position: Q2 2026 in Review
Jump Financial reduced its Quest Diagnostics (DGX) stake by 63% in Q2 2026, selling an estimated $395K and leaving 1,177 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #1754.
Jump Financial first reported a position in DGX in Q3 2020 and has held it in 19 quarters since. The position peaked at $3.33M in Q3 2021. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Jump Financial held 1,177 shares of Quest Diagnostics worth $249K as of Q2 2026.
- Jump Financial sold 2,013 Quest Diagnostics shares in Q2 2026, an estimated $395K.
- Quest Diagnostics made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1754 holding.
- Jump Financial first reported a position in Quest Diagnostics in Q3 2020 and has held it in 19 quarters since.
- Jump Financial's Quest Diagnostics position peaked at $3.33M in Q3 2021.
- 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.